Incidence, Risk Factors and Endoscopic Retrieval of Proximally Migrated Pancreatic Stents

Completed

• Conditions: Pancreatic Stent Displacement; Pancreatic Stenting

• Registration Number: NCT05431517
• Lead Sponsor: Changhai Hospital

Brief Summary

This study intends to determine the incidence, risk factors and endoscopic treatment of proximally migrated pancreatic stents.

Detailed Description

Endoscopic pancreatic stenting can be used to treat a variety of pancreatic disorders, including chronic pancreatitis-induced pancreatic duct stenosis, pancreatic schizophrenia, pancreatic leakage, pancreatic pseudocyst drainage, and prophylactic pancreatic duct stenting. Postoperative stent migration is one of the complications associated with pancreatic stent placement.

In this retrospective study, more than 9,000 Endoscopic retrograde cholangiopancreatography (ERCP) cases at our center over the past 25 years will be analyzed to determine the incidence, risk factors and endoscopic treatment of proximally migrated pancreatic stents.

Study Timeline

• Study First Submitted: 2022-06-19
• Study First Submitted QC: 2022-06-19
• Study First Posted: 2022-06-24
• Study Start: 2022-06-30
• Primary Completion: 2022-07-01
• Study Completion: 2022-07-31
• Status Verified: 2022-09
• Last Update Submitted: 2022-09-13
• Last Update Posted: 2022-09-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 9073

Inclusion Criteria

• Pancreatic stent placement under ERCP;
• Pancreatic stent migration found by ERCP;
• Displaced pancreatic stent removal by ERCP technique.

Exclusion Criteria

• Incomplete ERCP records (e.g., missing stent size information);
• Immediate removal of pancreatic stent following implantation for a variety of reasons.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of proximally migrated pancreatic stents	Within 1 month after data analysis
Success rate of endoscopic removal of migrated pancreatic stents	Within 1 month after data analysis

Trial Locations

Locations (1)

Changhai Hospital; 🇨🇳 Shanghai, China